Skip to main content
. 2014 May 16;5:10.3402/ejpt.v5.23911. doi: 10.3402/ejpt.v5.23911

Table 2.

Clinical characteristics of the three KIVS groups

KIVS group Low (n=30) Medium high (n=22) High (n=40) Statistics p
Mean age (SD) 28 (±6.75) 30 (±7.80) 30 (±8.1) F (2,89)=0.67 0.52
Axis I diagnose 29 (97%) 21 (95%) 40 (100%) χ 2=0.06 0.81
Additional Axis II diagnose (1 or more) 12 (40%) 15 (68%) 23 (58%) χ 2=4.04 0.13
PTSD 10/30 (33%) 8/22 (36%) 31/40 (78%) χ 2=16.75, τ=0.43 0.0002
χ 2=13.78, τ=0.43 0.0002 (L vs. H)
χ 2=10.29, τ=0.38 0.001 (M vs. H)
χ 2=0.05, τ=0.03 0.82 (L vs. M)
Medication, any psychoactive medication 16 (53%) 14 (64%) 28 (70%) χ 2=2.04 0.36
Antidepressants 14 (46%) 11 (50%) 20 (50%) χ 2=0.09 0.96
Lithium 1 2 0
No medication 2 2 3
No registered records of medication 10 (33%) 5 (23%) 9 (23%) χ 2=1.2 0.55

All estimated shown in bold are significant at p<0.05. KIVS=Karolinska Interpersonal Violence Scale, L=low: KIVS rating 0–1, M=medium high: KIVS rating 2–3, H=high: KIVS rating 4–5. ⊗=statistical analysis was not performed. No registered records of medication=data missing due to changes in research protocol. τ = Kendall's tau-c.